For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260108:nRSH0740Oa&default-theme=true
RNS Number : 0740O CVS Group plc 08 January 2026
08 January 2026
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 07 January 2026 it purchased the following number of its
ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 07/01/2026
Aggregate number of Ordinary Shares purchased: 31,334
Lowest price paid per share (GBp): 1,282.00
Highest price paid per share (GBp): 1,334.00
Volume weighted average price paid per share (GBp): 1,292.16
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,612,529 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,612,529 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,128,254 Ordinary Shares in aggregate at a weighted average price
of 1,226.76 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
136 1284 07/01/2026 08:01:13 1366307089943028 XLON
154 1284 07/01/2026 08:01:13 1366307089943029 XLON
35 1282 07/01/2026 08:52:01 1366307089951662 XLON
68 1284 07/01/2026 08:56:13 1366307089952051 XLON
68 1284 07/01/2026 09:45:50 1366307089958307 XLON
32 1284 07/01/2026 09:46:42 1366307089958401 XLON
362 1286 07/01/2026 09:47:15 1366307089958454 XLON
248 1286 07/01/2026 09:47:23 1366307089958461 XLON
68 1288 07/01/2026 09:54:25 1366307089959166 XLON
903 1292 07/01/2026 09:55:47 1366307089959269 XLON
774 1292 07/01/2026 09:55:47 1366307089959276 XLON
800 1288 07/01/2026 09:56:54 1366307089959332 XLON
111 1286 07/01/2026 10:03:59 1366307089959792 XLON
646 1286 07/01/2026 10:03:59 1366307089959793 XLON
309 1286 07/01/2026 10:06:40 1366307089959978 XLON
992 1288 07/01/2026 10:24:22 1366307089961710 XLON
596 1290 07/01/2026 10:29:16 1366307089962332 XLON
68 1290 07/01/2026 10:29:58 1366307089962441 XLON
944 1288 07/01/2026 10:51:11 1366307089964045 XLON
798 1288 07/01/2026 10:57:56 1366307089964398 XLON
188 1288 07/01/2026 10:57:56 1366307089964399 XLON
68 1288 07/01/2026 10:58:04 1366307089964409 XLON
428 1288 07/01/2026 10:59:29 1366307089964510 XLON
68 1290 07/01/2026 11:00:46 1366307089964626 XLON
68 1290 07/01/2026 11:04:18 1366307089964981 XLON
971 1288 07/01/2026 11:06:32 1366307089965114 XLON
959 1288 07/01/2026 11:16:29 1366307089965758 XLON
955 1288 07/01/2026 11:16:29 1366307089965760 XLON
954 1288 07/01/2026 11:23:27 1366307089966124 XLON
793 1288 07/01/2026 11:24:25 1366307089966171 XLON
159 1288 07/01/2026 11:24:25 1366307089966172 XLON
863 1290 07/01/2026 11:27:48 1366307089966506 XLON
454 1288 07/01/2026 11:28:39 1366307089966642 XLON
782 1294 07/01/2026 11:32:33 1366307089966905 XLON
778 1294 07/01/2026 11:32:33 1366307089966907 XLON
769 1292 07/01/2026 11:32:41 1366307089966916 XLON
303 1290 07/01/2026 11:32:49 1366307089966924 XLON
400 1290 07/01/2026 11:33:17 1366307089966960 XLON
600 1292 07/01/2026 11:33:43 1366307089966990 XLON
68 1292 07/01/2026 11:34:02 1366307089967011 XLON
346 1294 07/01/2026 11:37:35 1366307089967394 XLON
183 1294 07/01/2026 11:37:35 1366307089967397 XLON
75 1292 07/01/2026 11:41:54 1366307089967767 XLON
171 1292 07/01/2026 11:41:54 1366307089967769 XLON
147 1290 07/01/2026 12:00:00 1366307089969490 XLON
139 1290 07/01/2026 12:17:52 1366307089970563 XLON
110 1290 07/01/2026 12:17:52 1366307089970567 XLON
208 1290 07/01/2026 12:26:20 1366307089971235 XLON
68 1294 07/01/2026 12:27:25 1366307089971337 XLON
717 1292 07/01/2026 12:48:43 1366307089972621 XLON
160 1294 07/01/2026 12:58:55 1366307089973331 XLON
477 1292 07/01/2026 12:59:16 1366307089973356 XLON
92 1292 07/01/2026 13:03:10 1366307089973788 XLON
701 1292 07/01/2026 13:07:50 1366307089974233 XLON
81 1292 07/01/2026 13:07:56 1366307089974237 XLON
172 1292 07/01/2026 13:07:56 1366307089974238 XLON
70 1292 07/01/2026 13:08:59 1366307089974381 XLON
19 1290 07/01/2026 13:16:03 1366307089975154 XLON
114 1290 07/01/2026 13:16:03 1366307089975155 XLON
736 1292 07/01/2026 13:48:54 1366307089978029 XLON
736 1294 07/01/2026 13:49:22 1366307089978071 XLON
381 1294 07/01/2026 13:49:22 1366307089978072 XLON
741 1292 07/01/2026 13:50:36 1366307089978192 XLON
742 1292 07/01/2026 13:53:01 1366307089978354 XLON
754 1290 07/01/2026 13:54:10 1366307089978490 XLON
773 1294 07/01/2026 14:03:16 1366307089979302 XLON
724 1294 07/01/2026 14:12:20 1366307089980604 XLON
716 1292 07/01/2026 14:12:37 1366307089980635 XLON
765 1302 07/01/2026 14:14:49 1366307089980895 XLON
342 1302 07/01/2026 14:14:49 1366307089980897 XLON
217 1334 07/01/2026 15:18:28 1366307089995469 XLON
917 1330 07/01/2026 15:18:39 1366307089995492 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPUPWGUPQGBM
Copyright 2019 Regulatory News Service, all rights reserved